Advertisement

Topics

Companies Related to "Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients" [Most Relevant Company Matches] - Page: 5 RSS

18:15 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients" found in our extensive corporate database of over 50,000 company records.

Showing "Effect Ferrlecit Versus Oral Iron Iron Deficient Chronic" Companies 101–125 of 1,300+

Probably Relevant

izun Pharmaceuticals

Izun Pharmaceuticals Ltd. is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments. The Company's core technology utilizes naturally derived pharmaceutical actives for the treatment of oral disease with inflammatory components. The novel therapies co...


Metris Therapeutics

Established in 1996, Metris now has several products in development. These are a treatment for endometriosis, a treatment for menorrhagia / dysmenorrhea, using a proprietary vaginal drug delivery system, and an oral treatment for chronic symptoms associated with the menopause. Metris intends to license its products to third parties for late stage clinical development and commercialisation. Metris ...

OraPharma Incorporated

OraPharma, Inc., a specialty pharmaceutical company founded in 1996 with an initial focus on the emerging field of oral health care, discovers, develops and commercializes therapeutics for oral health. OraPharma's initial product, ArestinTM, represents a promising therapeutic advance for the adjunct treatment of periodontal disease. Arestin is the first locally administered time-released antibioti...


DOR BioPharma

DOR BioPharma, Inc. is a biopharmaceutical company addressing life-threatening side effects of cancer and cancer treatments, serious gastrointestinal diseases and disorders, and biomedical countermeasures. Our lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally-acting corticosteroid being developed for the treatment of gastrointestinal Graft-versus-Host disease (GI GVHD)...

Imposter Research

IMPOSTER is the name of a medical research study of patients with muscle symptoms while taking cholesterol lowering therapies called statins. Several important findings from this study have been published and have raised questions about the safety of statin therapy for patients with muscle complaints. This website was developed to address those questions and to share what is known about statin mu...

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical tri...

Unigene Laboratories

Unigene Laboratories, Inc. is a biopharmaceutical company engaged in the research, production and delivery of valuable therapeutic peptide hormones. The Company has patented manufacturing technology for producing amidated peptides cost-effectively and in quantities sufficient to support the worldwide commercialization of peptide therapeutics for oral delivery. The Company has also patented novel o...

Centrexion Therapeutics

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and aims to develop new, safer and more effective therapies that overcome the li...

Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc. is a drug development company founded in 2011 focused on developing T111 for the severe chronic itching condition known as pruritus. Pruritus is manifested in various dermatological, metabolic, hematologic and neuronal conditions. The Company is pursuing uremic pruritus as the lead indication. Uremic pruritus is a persistent ...

Head and Neck Cancer Alliance

Oral, head & neck cancer (OHNC) refers to a variety of cancers that develop in the head and neck region, such as: the oral cavity (mouth); the pharynx (throat); paranasal sinuses and nasal cavity; the larynx (voice box); thyroid and salivary glands; the skin of the face and neck; and the lymph nodes in the neck.

Rainbow Medical

Rainbow Medical, a private operational investment company, currently holds a portfolio of 12 companies that are developing products for the treatment of a range of chronic indications such as heart disease, diabetes, hypertension, blindness, uterine fibroids, chronic neuropathic pain, and others.

OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations...

Delta Dental of Illinois

The Delta Dental of Illinois Foundation (DDILF) was formed in March 2008 by Delta Dental of Illinois (DDIL), a not-for-profit dental service corporation with a mission to improve the oral health of the communities it serves. DDILF is the charitable arm of DDIL and works to support and improve the oral health of people in Illinois. In the past decade, combi...

NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow t...

IntraBiotics Pharmaceuticals Incorporated

The mission of IntraBiotics is to develop and commercialize novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases. IntraBiotics has developed two new antibiotics, Ramoplanin Oral and Protegrin IB-367 Rinse, to the third stage of clinical trials. Ramoplanin Oral and Protegrin IB-367 Rinse are both new types of antibiotics that may address major medi...

Children’s Dental Health Project

The Children's Dental Health Project advances policies that improve children's access to oral health through research-driven policies and innovative solutions by engaging a broad base of partners committed to children and oral health. For additional information please visit, www.cdhp.org.

WellDoc

WellDoc®, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, is focused on simplifying the way chronic diseases are managed through a collaborative, life-changing approach that breaks down the barriers of engagement and therapy adherence by providing patients and their heal...

Chronic Care Management, Inc.

Chronic Care Management Inc. is a private company located in San Antonio, Texas, dedicated to providing advanced personal disease management systems and enterprise level solutions for health care organizations, clinics and hospitals. Chronic Care Management, Inc. operates VirtualHealthCheck.com to help health organizations provide true between-visit care. Both VirtualHealthCheck.com and MyVirtualH...

Zila, Inc.

Zila, Inc., headquartered in Scottsdale, Arizona, is a diagnostic company dedicated to the prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite(R) Plus with TBlue(R) ("ViziLite(R) Plus"), the company's flagship product for the early detection of oral abnormalities that could lead to cancer. ViziLite(R) Plus is an adjunctive medical de...

Oral Reconstruction Foundation

The Oral Reconstruction Foundation is a not-for-profit private foundation with the primary goal of providing quality dental reconstructive continuing education to facilitate the exchange of knowledge between dental practitioners. As a continuing education provider, the OR Foundation presents and supports lectures, seminars, hands-on courses and surgical pa...

Contura Inc.

Aquamid is composed of 97.5% water for injection and 2.5% cross-linked polyacrylamide. The patented hydrogel is homogeneous: it contains no micro particles; hence its filling effect is due solely to the injected volume. Unlike particle-based fillers, the hydrogel does not rely on an intended foreign body reaction to achieve the desired augmentation. Therefore, the filling effect is immediate and p...

KOS Pharmaceuticals Incorporated

Kos Pharmaceuticals, Inc. is a fully-integrated specialty pharmaceutical company engaged in the development of proprietary prescription products for the treatment of certain chronic cardiovascular and respiratory diseases. The Company manufactures its lead product, NIASPAN, and markets such product directly through its own specialty sales force. The Company's cardiovascular products under developm...

Sinexus, Inc.

Sinexus, Inc. (http://www.sinexusinc.com) is a development-stage medical device company that is pioneering novel therapies for Ear, Nose & Throat (ENT) physicians to utilize in providing improved treatment for their patients. Sinexus' initial focus is treating patients with Chronic Rhinosinusitis, a debilitating chronic condition that affects one out of seven adults in the United States.

Hoy Health, LLC

Hoy Health LLC, is a first-of-its-kind health-tech platform that provides a comprehensive and integrated bilingual healthcare support ecosystem to medically underserved patients offering solutions relative to medication access, medication adherence, tele-health and chronic condition management programs. Hoy Health’s core businesses include HoyMEDS, a ...

ProBiora Health, LLC

ProBiora Health, LLC, develops and markets a complete line of proprietary probiotics that are specifically designed to enhance oral health for people and pets. In 2008, a line of consumer, professional and pet oral care products based on the research of Dr. Jeffrey Hillman was introduced under the Evora brand name. In 2009, both the EvoraPlus® and th...


More From BioPortfolio on "Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks